| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/03/2002 | EP1218397A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 07/03/2002 | EP1218396A1 Antibodies specific for fullerenes |
| 07/03/2002 | EP1218395A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 07/03/2002 | EP1218393A1 Cell targeting compositions and methods of using the same |
| 07/03/2002 | EP1218076A2 Method for sequencing reaction cleanup by constant pressure differential ultrafiltration |
| 07/03/2002 | EP1218036A1 Cell based assay |
| 07/03/2002 | EP1218035A2 Rapid peg-modification of viral vectors |
| 07/03/2002 | EP1218033A2 Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
| 07/03/2002 | EP1218019A2 Oncolytic virus |
| 07/03/2002 | EP1217989A1 Liposome-entrapped dna oral vaccines |
| 07/03/2002 | EP1201758A9 Microorganisms and method for L-arginine production by fermentation |
| 07/03/2002 | EP1181351A4 Method of purifying heterologous proteins |
| 07/03/2002 | EP1174522A9 TCF-1 nucleotide sequence variation |
| 07/03/2002 | EP1133513A4 Multidomain polynucleotide molecular sensors |
| 07/03/2002 | EP1077831B1 Twin frame seat assembly |
| 07/03/2002 | EP1066393B1 Expression system for producing proteins |
| 07/03/2002 | EP1034292B1 Cell-specific retroviral vectors with antibody domains and method for the production thereof for selective gene transfer |
| 07/03/2002 | EP1030690B1 Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
| 07/03/2002 | EP1012174A4 Nik proteins, nucleic acids and methods |
| 07/03/2002 | EP1007737A4 System for providing a polymorphism database |
| 07/03/2002 | EP1002264A4 Method and apparatus for providing a bioinformatics database |
| 07/03/2002 | EP0892854B1 Assays and reagents for identifying anti-fungal agents, and uses related thereto |
| 07/03/2002 | EP0822990A4 Methods for generating and screening novel metabolic pathways |
| 07/03/2002 | EP0813423B1 Composition to inhibit osteolysis and metastasis |
| 07/03/2002 | EP0689610B1 Dna sequencing by mass spectrometry via exonuclease degradation |
| 07/03/2002 | EP0619324B1 HUMAN TYPE ANTIBODY REACTIVE WITH GPIIb/IIIa |
| 07/03/2002 | EP0584117B1 Modification of lignin synthesis in plants |
| 07/03/2002 | EP0578746B1 GENES WHICH INFLUENCE $i(PICHIA) PROTEOLYTIC ACTIVITY, AND USES THEREFOR |
| 07/03/2002 | EP0555357B1 Methods for modifying and detecting the effects on the interaction of modified polypeptides and target substrates |
| 07/03/2002 | EP0437576B1 Homologous recombination for universal donor cells and chimeric mammalian hosts |
| 07/03/2002 | CN1357050A Adenoviral vectors for treating disease |
| 07/03/2002 | CN1357049A Receptor based antagonists and mehtods of making and using |
| 07/03/2002 | CN1357048A Enhanced prodrug activation |
| 07/03/2002 | CN1357047A Recombinant fusion protein (vaccine) compsn. contg. same and method for prodn. thereof |
| 07/03/2002 | CN1357046A Chitinase chitin-binding fragments |
| 07/03/2002 | CN1357045A Outer surface proteins, their genes, and their use |
| 07/03/2002 | CN1357044A RNP originating in paramyxovirus |
| 07/03/2002 | CN1357043A Avirulent xanthomonas-campestris strains producing xanthan |
| 07/03/2002 | CN1357042A Interleukin-17 related mammalian cytokines, polynucleotides encoding them. uses |
| 07/03/2002 | CN1357041A Head trauma induced cytoplasmatic calcium binding protein |
| 07/03/2002 | CN1357040A Regulation of viral gene expression |
| 07/03/2002 | CN1357009A Humanized antibody specific for human 4-1BB and pharmaceutical compsn comprising same |
| 07/03/2002 | CN1357007A Expression of heparin-binding protein in recombinant mammalian cells |
| 07/03/2002 | CN1357006A Mage-A1 peptides presented by HLA class II molecules |
| 07/03/2002 | CN1357005A Process for partitioning of proteins |
| 07/03/2002 | CN1357004A Method and devices for detecting optical properties, esp. luminescence reactions and refraction behavious of molecules which are directly or indirectly bound on support |
| 07/03/2002 | CN1356391A Polypeptide expresxion box |
| 07/03/2002 | CN1356390A Human leukemia associated reverse transcription virus gene and its application |
| 07/03/2002 | CN1356389A Plant transgenic method without selective marker |
| 07/03/2002 | CN1356388A Transgenic saline algae bio-reactor |
| 07/03/2002 | CN1356341A Anti-idiotype microantibody and its preparing process and application |
| 07/03/2002 | CN1356340A Single-chain antibody A1 for recognizing white-spot baculovirus of prawn and its usage |
| 07/03/2002 | CN1356339A High-expression gene of liver cancer, protein coded by it and its application |
| 07/03/2002 | CN1356259A Modified nano silicon particles |
| 07/02/2002 | US6414223 Brassica plant producing seeds having long chain monounsaturated fatty acid content of 82% and erucic acid content of 15%, selected from brassica napus, brassica juncea, and brassica rapa |
| 07/02/2002 | US6414222 Plant with double heterozygote allele; resistant to cyclohexanedione or aryloxyphenoxypropanoic acid herbicides |
| 07/02/2002 | US6414221 Transiently activated stress-inducible plant promoters |
| 07/02/2002 | US6414220 Galanin transgenic mice |
| 07/02/2002 | US6414219 Trangenic mouse whose germ cells comprose homozygous null mutation in endogenous nucleic acid sequence; neomycin cassette inserted in reverse orientation to osteopontin transcription; drug screening |
| 07/02/2002 | US6414136 Adsorption of fluorescent dye-labeled molecules not incorporated in polymer onto hydrophobic material after passing through hydrophilic matrix |
| 07/02/2002 | US6414134 Regulation of bcl-2 gene expression |
| 07/02/2002 | US6414132 Method of eliminating inhibitory/instability regions of mRNA |
| 07/02/2002 | US6414130 Polypeptides binds to extracellular domain, glycosylated polypeptide or monoclonal antibody; antitumor agents |
| 07/02/2002 | US6414129 Cells containing expression vectors; diagnosis; immunomodulator detection; genetic engineering |
| 07/02/2002 | US6414128 Leptin ligand binding; medical diagnosis, therapy, agonists, and antagonists; genetic engineering |
| 07/02/2002 | US6414124 Solvent extraction with alcohol and water; heating, cooling, precipitation; acidic dialysis with formic acid solution |
| 07/02/2002 | US6414120 Mammalian deep orange proteins |
| 07/02/2002 | US6414118 Amino acid sequence of chemokine induced by interferon-beta; for screening interferon mimics and suppressors |
| 07/02/2002 | US6414117 Compositions and methods for the treatment and diagnosis of immune disorders |
| 07/02/2002 | US6414116 Immunoreactive regions of glycoprotein GPII of varicella zoster virus |
| 07/02/2002 | US6414115 Parasitic nematode transglutaminase proteins and uses thereof |
| 07/02/2002 | US6414113 Amino acid sequence of peptide; for purifying and detecting bone marrow stromal cell antigen-1 |
| 07/02/2002 | US6413943 Methods and reagents for inhibiting proliferation of smooth muscle cells |
| 07/02/2002 | US6413942 Methods of delivering a physiologically active polypeptide to a mammal |
| 07/02/2002 | US6413939 Inducible phosphofructokinase and the Warburg effect |
| 07/02/2002 | US6413934 Biotin binding zones |
| 07/02/2002 | US6413933 Growth factor HTTER36 |
| 07/02/2002 | US6413932 Tek antagonists comprising soluble tek extracellular binding domain |
| 07/02/2002 | US6413792 Ultra-fast nucleic acid sequencing device and a method for making and using the same |
| 07/02/2002 | US6413777 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 07/02/2002 | US6413776 High throughput screening of gene function using adenoviral libraries for functional genomics applications |
| 07/02/2002 | US6413775 Polyamine analog-activated SSAT gene therapy |
| 07/02/2002 | US6413774 Producing recombinant nucleic acid using cycles of hybridization, chain extension, and denaturation; then transferring into cells for recombining |
| 07/02/2002 | US6413771 Respiratory syncytial virus (rsv) fusion protein; treating or preventing rsv infection, as well as for diagnosis of rsv in analytes |
| 07/02/2002 | US6413770 NL4 tie ligand homologue nucleic acid |
| 07/02/2002 | US6413769 α(1,3) galactosyltransferase negative porcine cells |
| 07/02/2002 | US6413768 Maintenance system; plasmid has restricted copy number origin of replication with transcriptional terminators, a selection marker, a post-segregational killing system, and an inducible promoter |
| 07/02/2002 | US6413765 Genetically modified lactic acid bacteria having modified diacetyl reductase activities |
| 07/02/2002 | US6413764 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof |
| 07/02/2002 | US6413762 Viral nucleotide sequences |
| 07/02/2002 | US6413760 Highly purified mocarhagin cobra venom protease polynucleotides endcoding same and related proteases and therapeutic uses thereof |
| 07/02/2002 | US6413759 Streptokinase mutants |
| 07/02/2002 | US6413758 Dna for enzyme isolated from bacillus pumilus; for genetic engineering |
| 07/02/2002 | US6413757 Nucleotide and amino acid sequence of enzyme; for use in vectors and host cells |
| 07/02/2002 | US6413756 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/02/2002 | US6413755 Human checkpoint kinase, HCDS1, compositions and methods |
| 07/02/2002 | US6413754 Candida albicans protein kinase which lacks a specific motif and has non-cyclin dependent cdk-activating activity; drug screening for fungicides |
| 07/02/2002 | US6413752 Protein capable of catalyzing transamination stereoselectively, gene encoding said protein and use thereof |
| 07/02/2002 | US6413750 Enzyme having mutation in n-terminal sequence which changes alkalinity of cofactor binding site |
| 07/02/2002 | US6413745 Recombination of insertion modified nucleic acids |